Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
Nat Cancer
.
2022 Sep;3(9):1137.
doi: 10.1038/s43018-022-00420-y.
Authors
Thomas Walle
#
1
2
3
,
Sunanjay Bajaj
#
4
5
,
Joscha A Kraske
5
,
Thomas Rösner
5
,
Christiane S Cussigh
6
,
Katharina A Kälber
6
,
Lisa Jasmin Müller
7
,
Sophia Boyoung Strobel
6
,
Jana Burghaus
6
,
Stefan M Kallenberger
5
,
Christoph K Stein-Thöringer
5
8
,
Maximilian Jenzer
5
,
Antonia Schubert
5
9
10
11
,
Steffen Kahle
5
,
Anja Williams
5
,
Birgit Hoyler
4
,
Lin Zielske
12
,
Renate Skatula
12
,
Stefanie Sawall
4
,
Mathias F Leber
4
5
,
Russell Z Kunes
13
,
Johannes Krisam
14
,
Carlo Fremd
5
15
,
Andreas Schneeweiss
15
,
Jürgen Krauss
5
,
Leonidas Apostolidis
5
,
Anne Katrin Berger
5
,
Georg M Haag
5
16
,
Stefanie Zschäbitz
5
,
Niels Halama
5
17
18
,
Christoph Springfeld
5
,
Romy Kirsten
12
,
Jessica C Hassel
6
,
Dirk Jäger
5
16
;
NCT ANTICIPATE Investigators
;
Guy Ungerechts
4
5
19
20
Collaborators
NCT ANTICIPATE Investigators
:
Omar Abdelrahim
,
Elena Busch
,
Patrick Derigs
,
Katharina Dischinger
,
Fouad Mitri
,
Kerstin Schmidt
,
Irfan A Bhatti
,
Barbara Grün
,
Nicolas Hohmann
,
Lena Woydack
,
Xin-Wen Zhang
,
Dyke Ferber
,
Andreas Mock
,
Tillmann Pompecki
,
Timo Schank
,
Carlo Fremd
,
Georg M Haag
,
Niels Halama
,
Romy Kirsten
,
Jessica C Hassel
,
Dirk Jäger
Affiliations
1
Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.
2
Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. t.walle@dkfz.de.
3
German Cancer Consortium (DKTK), Heidelberg, Germany. t.walle@dkfz.de.
4
Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
5
Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
6
Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
7
Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany.
8
Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
9
German Cancer Consortium (DKTK), Heidelberg, Germany.
10
BioQuant & Department of Cell and Molecular Biology, Heidelberg University, Heidelberg, Germany.
11
Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
12
NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
13
Department of Statistics, Columbia University, New York, NY, USA.
14
Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
15
Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
16
Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
17
Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
18
Helmholtz Institute for Translational Oncology (HITRON), Mainz, Germany.
19
CanVirex, Heidelberg, Germany.
20
Ottawa Hospital Research Institute, Cancer Therapeutics Program, Ottawa, Ontario, Canada.
#
Contributed equally.
PMID:
35840692
PMCID:
PMC9284954
DOI:
10.1038/s43018-022-00420-y
No abstract available
Publication types
Published Erratum